Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Dutasteride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1

Interventions

Cyclophosphamide 21 venetoclax 19 Dexamethasone 17 pembrolizumab 16 fludarabine 14 Cytarabine 13 Gemcitabine 10 Azacitidine 9 pomalidomide 8 Rituximab 8 Lenalidomide 8 Carboplatin 8 selinexor 7 glofitamab 7 fludarabine phosphate 7 Cisplatin 7 daratumumab 6 Temozolomide 6 Paclitaxel 6 Injections 6 Granulocyte Colony-Stimulating Factor 6 Oxaliplatin 5 Immunotherapy, Adoptive 5 Decitabine 5 ruxolitinib 4 Surgical Procedures, Operative 4 Nivolumab 4 Drug Therapy 4 Cladribine 4 Calcium Dobesilate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07420517 2026-03-30

DutaBCa-1

CHU de Quebec-Universite Laval

Phase 2 Recruiting

Urinary Bladder Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡